SG11201608093WA - A therapeutic agent for use in the treatment of infections - Google Patents

A therapeutic agent for use in the treatment of infections

Info

Publication number
SG11201608093WA
SG11201608093WA SG11201608093WA SG11201608093WA SG11201608093WA SG 11201608093W A SG11201608093W A SG 11201608093WA SG 11201608093W A SG11201608093W A SG 11201608093WA SG 11201608093W A SG11201608093W A SG 11201608093WA SG 11201608093W A SG11201608093W A SG 11201608093WA
Authority
SG
Singapore
Prior art keywords
infections
treatment
therapeutic agent
therapeutic
agent
Prior art date
Application number
SG11201608093WA
Other languages
English (en)
Inventor
Adrian Neville Fellows
Original Assignee
Aga Nanotech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aga Nanotech Ltd filed Critical Aga Nanotech Ltd
Publication of SG11201608093WA publication Critical patent/SG11201608093WA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/132—Amines having two or more amino groups, e.g. spermidine, putrescine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Nanotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
SG11201608093WA 2014-04-01 2015-03-24 A therapeutic agent for use in the treatment of infections SG11201608093WA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1405874.7A GB201405874D0 (en) 2014-04-01 2014-04-01 A therapeutic agent for use in the treatment of infections
GBGB1415063.5A GB201415063D0 (en) 2014-04-01 2014-08-26 A therapeutic agent for use in the treatment of infections
PCT/GB2015/000100 WO2015150722A1 (en) 2014-04-01 2015-03-24 A therapeutic agent for use in the treatment of infections

Publications (1)

Publication Number Publication Date
SG11201608093WA true SG11201608093WA (en) 2016-10-28

Family

ID=50737835

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201801524PA SG10201801524PA (en) 2014-04-01 2015-03-24 A therapeutic agent for use in the treatment of infections
SG11201608093WA SG11201608093WA (en) 2014-04-01 2015-03-24 A therapeutic agent for use in the treatment of infections

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG10201801524PA SG10201801524PA (en) 2014-04-01 2015-03-24 A therapeutic agent for use in the treatment of infections

Country Status (16)

Country Link
US (2) US9913805B2 (de)
EP (2) EP3848022B1 (de)
JP (1) JP6573286B2 (de)
KR (2) KR102359855B1 (de)
CN (1) CN106456557B (de)
AU (1) AU2015242495B2 (de)
CA (1) CA2943431C (de)
DK (1) DK3125874T3 (de)
ES (2) ES2855985T3 (de)
GB (3) GB201405874D0 (de)
IL (1) IL247969B (de)
MX (1) MX2016012757A (de)
NZ (1) NZ724298A (de)
SG (2) SG10201801524PA (de)
WO (1) WO2015150722A1 (de)
ZA (1) ZA201606387B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201405874D0 (en) * 2014-04-01 2014-05-14 Aga Nanotech Ltd A therapeutic agent for use in the treatment of infections
CN107281220B (zh) * 2016-03-31 2020-02-14 中国科学院上海硅酸盐研究所 一种介孔氧化硅基活性氧(ros)放疗增敏剂及其制备方法
CN106860032B (zh) * 2016-10-25 2021-04-09 咏达生医材料股份有限公司 一种气态皮肤供氧美白产品及其应用
JP2019194162A (ja) * 2018-05-01 2019-11-07 ツァ ギャリー 肌の酸素供給による美白及び加熱機能を備えた通気性材料
GB2592911B (en) 2020-02-28 2023-06-28 Aga Nanotech Ltd A plasma-activatable wound dressing for treatment of infections
GB202005556D0 (en) 2020-04-16 2020-06-03 Aga Nanotech Ltd Covid face mask

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997007777A1 (en) * 1995-08-15 1997-03-06 Robert Eric Montgomery Peroxidase-activating oral compositions
EP1064910B1 (de) 1999-07-02 2005-09-14 Cognis IP Management GmbH Mikrokapseln - IV
EP1187602A4 (de) * 2000-04-18 2004-09-15 Peptron Inc Injizierbare pharmazeutische zusammensetzung mit verzögerter freisetzung und verfahren zu deren herstellung
KR100342746B1 (ko) * 2000-06-27 2002-07-03 김찬화 인슐린의 방출제어제제 및 그 방법
GB0411304D0 (en) * 2004-05-21 2004-06-23 Fellows Adrian N An antimicrobial composition
US20060088498A1 (en) 2004-10-27 2006-04-27 Truox, Inc. Anti-microbial composition using in-situ generation of an oxidizing agent
EP1919507A2 (de) * 2005-08-04 2008-05-14 Thomas William Rademacher Nanoteilchen mit antibakteriellen liganden
KR20070071225A (ko) * 2005-12-29 2007-07-04 애경산업(주) 치아 미백용 조성물
GB0711952D0 (en) 2007-06-20 2007-08-01 King S College London Microspheres
EP2244698A1 (de) * 2008-02-25 2010-11-03 The University Of North Carolina At Charlotte Office Of Technology Transfer Biologisch abbaubare therapeutische nanopartikel mit einem antimikrobiellen mittel
JP2011528275A (ja) * 2008-07-17 2011-11-17 ミセル テクノロジーズ，インク． 薬物送達医療デバイス
US8969282B2 (en) * 2009-02-05 2015-03-03 American Sterilizer Company Low odor, hard surface sporicide
KR101136028B1 (ko) * 2009-04-27 2012-04-18 한양대학교 산학협력단 다공성 마이크로스피어의 제조방법
EP2424488B1 (de) * 2009-04-27 2023-06-07 Premier Dental Products Company Mikroverkapselte zusammensetzungen und verfahren für gewebemineralisierung
NZ600269A (en) 2009-05-20 2014-02-28 Dec Int Nz Ltd Delivery device for treatment of mastitis
US9187594B2 (en) * 2010-02-09 2015-11-17 The Regents Of The University Of Michigan Nano-fibrous microspheres and methods for making the same
ES2628931T3 (es) * 2010-07-09 2017-08-04 Innocore Technologies B.V. Copolímeros multibloque segmentados de fases separadas biodegradables y liberación de polipétidos biológicamente activos
CA2812063A1 (en) * 2010-08-30 2012-06-07 President And Fellows Of Harvard College Shear controlled release for stenotic lesions and thrombolytic therapies
GB201405874D0 (en) * 2014-04-01 2014-05-14 Aga Nanotech Ltd A therapeutic agent for use in the treatment of infections

Also Published As

Publication number Publication date
EP3848022B1 (de) 2023-06-07
GB2538923A (en) 2016-11-30
CN106456557B (zh) 2021-02-05
JP6573286B2 (ja) 2019-09-11
AU2015242495A1 (en) 2016-10-06
EP3848022A1 (de) 2021-07-14
SG10201801524PA (en) 2018-04-27
GB201617053D0 (en) 2016-11-23
EP3848022C0 (de) 2023-06-07
EP3125874B1 (de) 2020-12-30
ZA201606387B (en) 2017-11-29
GB2538923B (en) 2020-03-25
MX2016012757A (es) 2017-04-27
ES2953755T3 (es) 2023-11-15
ES2855985T3 (es) 2021-09-27
US10933026B2 (en) 2021-03-02
US9913805B2 (en) 2018-03-13
JP2017510648A (ja) 2017-04-13
CA2943431A1 (en) 2015-10-08
IL247969B (en) 2018-12-31
KR102482597B1 (ko) 2022-12-29
KR102359855B1 (ko) 2022-02-08
NZ724298A (en) 2022-07-01
CA2943431C (en) 2022-08-23
WO2015150722A1 (en) 2015-10-08
US20180207105A1 (en) 2018-07-26
EP3125874A1 (de) 2017-02-08
CN106456557A (zh) 2017-02-22
KR20160144408A (ko) 2016-12-16
KR20220021029A (ko) 2022-02-21
AU2015242495B2 (en) 2020-04-30
GB201415063D0 (en) 2014-10-08
US20170079930A1 (en) 2017-03-23
DK3125874T3 (da) 2021-03-22
GB201405874D0 (en) 2014-05-14

Similar Documents

Publication Publication Date Title
IL250685A0 (en) Medicinal substance induces cytotoxicity
GB201403093D0 (en) Therapeutic compounds and their use
IL254142B (en) Tredifitant for use in the treatment of a disease or medical condition that responds to Tredifitent
GB201410816D0 (en) Therapeutic agents
IL250990A0 (en) Materials for human care
IL247969B (en) A medicinal component for use in the treatment of infections
GB201502412D0 (en) Therapeutic use
GB201617064D0 (en) Compounds and their therapeutic use
HK1256164A1 (zh) 用於治療神經膠質瘤的製劑
GB201608797D0 (en) Therapeutic use
GB201410815D0 (en) Therapeutic agents
GB201410817D0 (en) Therapeutic agents
PL3160464T3 (pl) 6-hydroksybuspiron do stosowania w leczeniu zaburzeń ruchowych
IL246855A0 (en) Materials for use in the treatment of retinitis
LT3406258T (lt) Vaistas, skirtas podagros gydymui
GB201418809D0 (en) Therapeutic agents and uses thereof
GB201615844D0 (en) Agents for use in therapy
GB201409653D0 (en) Pyrrolobenzodiazepine therapeutic agents
HK1217430A1 (zh) 表面處理劑
GB201506786D0 (en) Therapeutic use
GB201911521D0 (en) Therapeutic agent
GB201516109D0 (en) Therapeutic agent
GB201506944D0 (en) Therapeutic treatment
GB201410387D0 (en) Compounds and their therapeutic use
GB201403496D0 (en) Compounds and their therapeutic use